The UK risks losing £11 billion ($14 billion) in pharmaceutical R&D investment by 2033 unless urgent reforms are made to high ...

German drugmaker STADA Arzneimittel has reported record earnings on revenues growth in its financial first quarter.

Shares in MaaT Pharma (Euronext: MAAT), a French microbiome company in oncology, closed 25% higher Tuesday. The company ...

Taiwanese biotech PharmaEssentia (TWSE: 6446) is preparing to seek an expanded US label for its long-acting interferon ...

Shanghai-based Mabwell Bioscience (SH: 688062) has secured approval from the Chinese regulator for its first locally ...

Germany-based mental health specialist atai Life Sciences is to buy privately-held UK psychedelic drug developer Beckley ...

Japanese biotech Nxera Pharma (TSE: 4565) has received a $15 million payment from Neurocrine Biosciences (Nasdaq: NBIX) after ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved SFL Pharmaceuticals Deutschland’s Aumseqa (aumolertinib) for adults with non-small cell lung cancer (NSCLC).

Swiss generic and biosimilar medicines company Sandoz (SWX: SDZ) today announced that Wyost (denosumab) and Jubbonti ...

Arcus Biosciences (NYSE: RCUS) is setting the stage for a high-stakes Phase III showdown in kidney cancer, after early ...

Detailed results from the Phase III OASIS-4 study have found that Bayer’s elinzanetant showed a statistically significant ...

AstraZeneca (LSE: AZN) has reported positive findings from its Phase III MATTERHORN trial, spotlighting the potential of its ...